Global COVID-19 Diagnostics Market

COVID-19 Diagnostics Market Size, Share, Growth Analysis, By Sample Type(Oropharyngeal swabs, nasopharyngeal, swabs, and blood), By Technology(Polymerase chain reaction, Enzyme-linked immunoassay (ELISA), and lateral flow immunoassay), By End users(Laboratories, hospitals, diagnostic centers and clinics, and others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35B2067 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 92 | Figures: 76

COVID-19 Diagnostics Market Competitive Landscape

The nature of competition in this market is very intense owing to the presence of multiple players. Partnerships with companies that provide free technology and investment to increase the production capacity of potential therapies are key strategies adopted by industry players to strengthen their market position.

COVID-19 Diagnostics Market Top Company Profiles

  • F. Hoffmann-La Roche AG

  • Abbott Laboratories

  • Thermo Fisher Scientific Inc.

  • Becton, Dickinson and Company

  • Siemens Healthineers AG

  • Danaher Corporation

  • QIAGEN N.V.

  • Bio-Rad Laboratories, Inc.

  • Hologic, Inc.

  • Ortho-Clinical Diagnostics, Inc.

  • Cepheid

  • Beckman Coulter, Inc.

  • GenMark Diagnostics, Inc.

  • PerkinElmer, Inc.

  • Sysmex Corporation

  • Seegene Inc.

  • BioFire Diagnostics, LLC

  • BioMérieux SA

  • ThermoGenesis Holdings, Inc.

  • Meridian Bioscience, Inc.

COVID-19 Diagnostics Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

COVID-19 Diagnostics Market size was valued at USD 95.2 billion in 2022 and is poised to grow from USD 102.53 billion in 2023 to USD 185.60 billion by 2031, growing at a CAGR of 7.70% in the forecast period (2024-2031).

The nature of competition in this market is very intense owing to the presence of multiple players. Partnerships with companies that provide free technology and investment to increase the production capacity of potential therapies are key strategies adopted by industry players to strengthen their market position. ' F. Hoffmann-La Roche AG ', ' Abbott Laboratories ', ' Thermo Fisher Scientific Inc. ', ' Becton, Dickinson and Company ', ' Siemens Healthineers AG ', ' Danaher Corporation ', ' QIAGEN N.V. ', ' Bio-Rad Laboratories, Inc. ', ' Hologic, Inc. ', ' Ortho-Clinical Diagnostics, Inc. ', ' Cepheid ', ' Beckman Coulter, Inc. ', ' GenMark Diagnostics, Inc. ', ' PerkinElmer, Inc. ', ' Sysmex Corporation ', ' Seegene Inc. ', ' BioFire Diagnostics, LLC ', ' BioMérieux SA ', ' ThermoGenesis Holdings, Inc. ', ' Meridian Bioscience, Inc. '

To deal with the COVID-19 crisis, governments across the world have implemented lockdowns. The government invested in the COVID-19 crisis and has been supporting health and life science industries in developing rapid treatment. FDA announced an emergency use authorization (EUA) pathway for the emergency use of therapies that help in the treatment of COVID-19. Several pharmaceuticals, biotechnology, and biopharmaceutical firms granted EUA approval which supports further clinical studies on therapy.

In vitro diagnostic, companies and governments have focused on developing more reliable tests, which provides faster results at lower costs. By July 2021, more than 500 COVID-19 POC diagnostic tests were available in the market.

The market size of North America is USD 11.97 billion in 2021, thus registering the fastest growth rate. The market in the region is expected to grow at a substantial level because of the sudden rise in COVID-19 cases and deaths in this region, so the demand for diagnosis and treatment increases.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Infectious Disease Diagnostics Market
Buy Now GET FREE SAMPLE
Influenza Diagnostics Market
Buy Now GET FREE SAMPLE
Rapid Diagnostics Market
Buy Now GET FREE SAMPLE
Companion Diagnostics Market
Buy Now GET FREE SAMPLE
Veterinary Infectious Disease Diagnostics Market
Buy Now GET FREE SAMPLE
Cancer Diagnostics Market
Buy Now GET FREE SAMPLE
Point Of Care Diagnostics Market
Buy Now GET FREE SAMPLE
Molecular Diagnostics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global COVID-19 Diagnostics Market

Report ID: SQMIG35B2067

$5,300
BUY NOW GET FREE SAMPLE